Page last updated: 2024-08-23

selegiline and scopolamine hydrobromide

selegiline has been researched along with scopolamine hydrobromide in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's8 (72.73)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA1
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Heinonen, E; Riekkinen, P; Sirviö, J; Yavich, L1
Diavolitsis, P; Dringenberg, HC; Laporte, PP1
Chodera, A; Kus, K; Nowakowska, E; Rybakowski, J1
Bruce, A; Dringenberg, HC; Rubenstein, ML; Solty, H; Tomaszek, S1
Foley, AG; Murphy, KJ; O'connell, AW; Regan, CM1
Kusumoto, H; Minami, A; Shimazu, S; Takahata, K; Yoneda, F1

Reviews

1 review(s) available for selegiline and scopolamine hydrobromide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

10 other study(ies) available for selegiline and scopolamine hydrobromide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations

2002
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:3

    Topics: Aging; Animals; Learning; Memory; Rats; Rats, Inbred Strains; Scopolamine; Selegiline; Space Perception

1993
Increased effectiveness of tacrine by deprenyl co-treatment in rats: EEG and behavioral evidence.
    Neuroreport, 2000, Nov-09, Volume: 11, Issue:16

    Topics: Animals; Cerebral Cortex; Cholinesterase Inhibitors; Drug Synergism; Electroencephalography; Male; Maze Learning; Monoamine Oxidase Inhibitors; Rats; Rats, Long-Evans; Reserpine; Scopolamine; Selegiline; Tacrine

2000
Investigating potential anxiolytic, antidepressant and memory enhancing activity of deprenyl.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2001, Volume: 52, Issue:4 Pt 2

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Male; Maze Learning; Memory; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Wistar; Scopolamine; Selegiline

2001
Electroencephalographic activation by tacrine, deprenyl, and quipazine: cholinergic vs. non-cholinergic contributions.
    European journal of pharmacology, 2002, Jun-28, Volume: 447, Issue:1

    Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Electroencephalography; Monoamine Oxidase Inhibitors; Muscarinic Antagonists; Prosencephalon; Quipazine; Rats; Rats, Long-Evans; Reserpine; Scopolamine; Selegiline; Serotonin Antagonists; Tacrine

2002
Chronic exposure of rats to cognition enhancing drugs produces a neuroplastic response identical to that obtained by complex environment rearing.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:1

    Topics: Acetylcholine; Amnesia; Animals; Avoidance Learning; Cognition; Dentate Gyrus; Dose-Response Relationship, Drug; Environment; GABA Antagonists; Maze Learning; Memory; Muscarinic Antagonists; Neural Cell Adhesion Molecules; Neuronal Plasticity; Neurons; Neuroprotective Agents; Nipecotic Acids; Nootropic Agents; Oximes; Pyrrolidinones; Rats; Scopolamine; Selegiline; Sialic Acids; Tacrine

2006
Effects of selegiline alone or with donepezil on memory impairment in rats.
    European journal of pharmacology, 2005, Aug-22, Volume: 518, Issue:2-3

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Aziridines; Behavior, Animal; Choline; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Drug Synergism; Escape Reaction; Fenclonine; Indans; Male; Maze Learning; Memory Disorders; Piperidines; Rats; Rats, Inbred F344; Reaction Time; Scopolamine; Selegiline; Time Factors

2005